142 results
Page 5 of 8
6-K
EX-99.1
mpjk0tyy 8u1pyfi2ski
27 Feb 15
Live Filing
12:00am
6-K
EX-99.1
icefnj3usaoe3ox2
25 Feb 15
Live Filing
12:00am
6-K
EX-99.1
qj1o4cf1 7m4n
24 Feb 15
TEVA ANNOUNCES POSITIVE RESULTS FOR TEV-48125 IN PHASE IIb CHRONIC MIGRAINE STUDY MEETING PRIMARY AND SECONDARY ENDPOINTS
12:00am
6-K
EX-99.1
2u2efdrn br13aah
23 Feb 15
Live Filing
12:00am
6-K
EX-99.1
iw50k s6ba3umi1ren
20 Feb 15
Teva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
12:00am
6-K
EX-99.1
sx5fxogjhg io56qf
5 Feb 15
Live Filing
12:00am
6-K
EX-99.1
t3d2iqowh
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
o9gwizrpca1t9
26 Jan 15
Teva Receives Fda Approval for First Generic Nexium® Delayed-release Capsules In the United States
12:00am
6-K
EX-99.1
91cz9farpkv30sxq
20 Jan 15
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE®20 mg/mL Case and Remand for Further Review
12:00am
6-K
EX-99.1
y3qldrv
7 Jan 15
Teva Launches Generic Diovan® In the United States
12:00am
6-K
EX-99.1
vstxvwxs
23 Dec 14
Live Filing
12:00am
6-K
EX-99.1
vsy01 0t80
19 Dec 14
First Waterless Nasal Allergy Spray Approved for Children as Young as Four Years of Age
12:00am
6-K
EX-99.1
knyv71nf
11 Dec 14
Teva Announces Launch of First Generic Celebrex® Capsules In the United States
12:00am
6-K
EX-99.1
ivlq4iw6wz5 ap4
11 Dec 14
Teva Provides 2015 Business Outlook
12:00am
6-K
EX-99.1
cmvwyk
4 Dec 14
Live Filing
12:00am
6-K
EX-99.1
sjn5k3ujr8mvi335
1 Dec 14
Teva Announces Launch of Generic Exforge HCT® Tablets In the United States
12:00am
6-K
EX-99.1
9ub wqo0cjccnrzky
1 Dec 14
Live Filing
12:00am
6-K
EX-99.1
j3smz wnt
26 Nov 14
Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
12:00am
6-K
EX-99.1
b6nob2km
18 Nov 14
Live Filing
12:00am